We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Devicemakers Call for Narrower Scope in Surgical Mesh Reclassification
Devicemakers Call for Narrower Scope in Surgical Mesh Reclassification
The FDA should exempt certain biologic grafts from its “sweeping proposed reclassification” of surgical mesh, Cook Biotech says in comments on a proposal to place mesh for transvaginal pelvic organ prolapse repairs in Class III.